IL2 and COVID-19: Most COVID-19 patients exhibit increased circulating levels of IL-6, IL-1b, and TNF, as well as IL-2, IL-8, reflecting the disease severity, which results in massive systemic immunosuppression [23-24] and in lymphopenia and neutrophilia, two key hematological features of COVID-19 [25-26].